Philips Announces 2026 Annual General Meeting of Shareholders
Royal Philips, the global health technology leader headquartered in Amsterdam, has formally convened its Annual General Meeting of Shareholders for 2026. The company has published the complete agenda along with detailed explanatory notes in preparation for the significant corporate event.
Key Board Appointments and Re-appointments
The agenda features several crucial proposals regarding the composition of Philips' leadership. A notable proposal includes the appointment of John DeFord as a new member of the Supervisory Board, effective from May 8, 2026. DeFord, an American born in 1962, is set to join the company's governing body.
Additionally, the company has put forward proposals for the re-appointment of three existing Supervisory Board members: Paul Stoffels (Belgian, 1962), Herna Verhagen (Dutch, 1966), and Sanjay Poonen (American, 1969). All three re-appointments are also scheduled to take effect from May 8, 2026.
In a move reinforcing executive leadership, Philips proposes to re-appoint Roy Jakobs as President, CEO, Chairman, and member of the Board of Management. Jakobs, who holds Dutch and German citizenship and was born in 1974, will continue in his multifaceted leadership role starting the same date.
Comprehensive Meeting Agenda
The 2026 AGM agenda extends beyond personnel matters to include substantial governance and financial proposals. A significant item is the proposal for a new Remuneration Policy for the Supervisory Board, which will be presented for shareholder consideration.
The meeting will also address several recurring annual items, including:
- An advisory vote on the 2025 Remuneration Report as included in the Annual Report 2025
- Proposals to adopt the company's financial statements for the previous fiscal year
- Consideration of dividend distribution options, either in cash or shares
Meeting Logistics and Documentation
The Annual General Meeting of Shareholders 2026 will be held at the Hotel Okura Amsterdam, located at Ferdinand Bolstraat 333 in Amsterdam. The gathering is scheduled for Friday, May 8, 2026, commencing at 10:00 Central European Time.
Philips has made all relevant documentation publicly available, including the complete agenda with explanatory notes, the Annual Report 2025 (originally published on February 19, 2026), binding nominations, the proposed Remuneration Policy for the Supervisory Board, and other materials pertinent to the meeting.
Company Background and Forward-Looking Statements
Royal Philips, traded on the New York Stock Exchange as PHG and on the Amsterdam Exchange as PHIA, remains a dominant force in health technology innovation. The company focuses on improving health and well-being through patient-centric solutions that leverage advanced technology and clinical insights.
With 2025 sales reaching EUR 18 billion and approximately 64,800 employees worldwide, Philips maintains operations in over 100 countries. The company excels in diagnostic imaging, ultrasound, image-guided therapy, monitoring systems, enterprise informatics, and personal health technologies.
The published materials include forward-looking statements regarding Philips' financial condition, operational results, business strategies, and future objectives. These statements inherently involve risks and uncertainties related to future events and circumstances that could cause actual outcomes to differ materially from current projections.
For additional information regarding the 2026 Annual General Meeting, interested parties can contact Michael Fuchs of Philips Global External Relations at +31 614869261 or Michael.Fuchs@philips.com, or Dorin Danu of Philips Investor Relations at +31 20 59 77055 or dorin.danu@philips.com.
